Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26750156 | 0.87 | ADORA2A (0.40) | LOXL2ACACBPSMB8CHRNA4ATM | |
| SCHEMBL20283946 | 0.85 | LOXL2 (0.38) | LOXL2ACACBPSMB8TSHRCHRNA4 | |
| SCHEMBL656888 | 0.78 | ATM (0.43) | ACACBCHRNA4ATMSMN1; SMN2NPC1 | |
| SCHEMBL3940897 | 0.78 | CHRNA4 (0.40) | LOXL2ACACBPSMB8CHRNA4ATM | |
| SCHEMBL20283847 | 0.77 | LATS1 (0.40) | ACACBTSHR | |
| Hydrochloric Acid SCHEMBL3938535 | 0.77 | CHRNA4 (0.39) | LOXL2ACACBPSMB8CHRNA4ATM | |
| SCHEMBL893060 | 0.76 | CHRNA4 (0.41) | ACACBPSMB8CHRNA4ATMSMN1; SMN2 | |
| SCHEMBL157610 | 0.76 | — | — | |
| SCHEMBL15704535 | 0.76 | MAOB (0.51) | TSHRCHRNA4ATMSMN1; SMN2NPC1 | |
| SCHEMBL19064377 | 0.76 | RAB9A (0.54) | ACACBATMSMN1; SMN2NPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10426168-B2 | Agent for controlling noxious arthropods | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20180168159-A1 | AGENT FOR CONTROLLING NOXIOUS ARTHROPODS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180168159-A1 | AGENT FOR CONTROLLING NOXIOUS ARTHROPODS | C3AR1, OPRM1, CHRM1 | PDCD1LG2 4426/4885CD274 3753/4885LOXL2 2102/4885 |
| US-10426168-B2 | Agent for controlling noxious arthropods | C3AR1, OPRM1, CHRM1 | PDCD1LG2 4426/4885CD274 3753/4885LOXL2 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.